Man

TOMÁS ANDRÉS ZAMBRANO COLOMA

RESEARCHER

ENVIRON SPA

SANTIAGO, Chile

Líneas de Investigación


FARMACOGENÉTICA, EPIGENÉTICA, BIOLOGÍA TUMORAL

Educación

  •  Biología Celular y Molecular, UNIVERSIDAD DE SAO PAULO. Chile, 2015

 

Article (24)

A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos
Effect of statins on lipid metabolism-related microRNA expression in HepG2 cells
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
Gender-Specific Association Between ABCC2-24C > T SNP and Reduction in Triglycerides in Chilean Patients Treated With Atorvastatin
Statins differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: A pilot study
Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects
Bacterial Community Profile of the Gut Microbiota Differs between Hypercholesterolemic Subjects and Controls
CYP2C19*2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls
Epigenetic Modifications of Major Depressive Disorder
HMGCR rs17671591 SNP Determines Lower Plasma LDL-C after Atorvastatin Therapy in Chilean Individuals
Polyphenol-Rich Extract from Propolis Reduces the Expression and Activity of Streptococcus mutans Glucosyltransferases at Subinhibitory Concentrations
Altered microRNome Profiling in Statin-Induced HepG2 Cells: A Pilot Study Identifying Potential new Biomarkers Involved in Lipid-Lowering Treatment
APOE Polymorphisms Contribute to Reduced Atorvastatin Response in Chilean Amerindian Subjects
Efficacy of Ezetimibe Is Not Related to NPC1L1 Gene Polymorphisms in a Pilot Study of Chilean Hypercholesterolemic Subjects
Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: A pilot study
SLCO1B1 c.388A > G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals
Influence of SREBP-2 and SCAP Gene Polymorphisms on Lipid-Lowering Response to Atorvastatin in a Cohort of Chilean Subjects with Amerindian Background
Effect of Five Single Nucleotide Polymorphisms of ABCG5 and ABCG8 Genes on Ezetimibe Lipid-Lowering Response
Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia
Frequency of Common Variants in Genes Involved in Lipid-Lowering Response to Statins in Chilean Subjects with Hypercholesterolemia
Frequency of common variants in genes involved in lipid-lowering response to statins in Chilean subjects with hypercholesterolemia Frecuencia de polimorfismos en genes relacionados a la respuesta terapéutica a estatinas en individuos Chilenos con hipercolesterolemia
Polimorfismo SNP-43 del gen de Calpaína-10 en individuos con enfermedad coronaria y controles

Abstract (2)

Differentially expressed microRNAs in human peripheral blood mononuclear cells are potential markers for statin response
PCSK9 23968 A > G gene polymorphism in chilean individuals with coronary artery disease and controls

ConferencePaper (1)

PCSK9 polymorphism rs505151 affects lipid-lowering response to atorvastatin but does not influence ezetimibe therapy in Chilean subjects

Proyecto (3)

EFFECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN ON MICRORNA EXPRESSION SIGNATURE IN MONONUCLEAR CELLS FROM HYPERCHOLESTEROLEMIC PATIENTS
Farmacogenômica de estatinas=> Regulação do perfil de expressão de miRNAs e genes alvo em células HepG2
Papel de estatinas na modulação de miRNAs em células mononucleares de pacientes hipercolesterolêmicos

Review (4)

The Current State of MicroRNAs as Restenosis Biomarkers
Involvement of cytochrome P450 in cisplatin treatment: implications for toxicity
Medicinal value of the Berberis genus as hypoglycemic agent
Medicinal value of the Berberis genus as hypoglycemic agent [Valor medicinal del género Berberis como agente hipoglicemiante]
29
TOMÁS ZAMBRANO

RESEARCHER

ENVIRON SPA

SANTIAGO, Chile

20
Luis Salazar

Profesor Titular

Ciencias Básicas

Universidad de La Frontera

Temuco, Chile

13
Nicolás Saavedra

Profesor Asociado

Departamento de Ciencias Básicas

Universidad de La Frontera

Temuco, Chile

9
Fernando Lanas

Profesor titular

Medicina Interna

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

5
Luis Salazar

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

5
Alvaro Cerda

Académico

Departamento de Ciencias Básicas

Universidad de La Frontera

Temuco, Chile

4
Alejandro Cuevas

Profesor Asistente

Departamento de Ciencias Preclínicas

Universidad de la Frontera

Temuco, Chile

4
Marysol Alvear

Académico e Investigador

Departamento de Ciencias Químicas y Recursos Naturales.

Universidad de La Frontera

Temuco, Chile

2
Nelson Varela

Académico

Oncología Básico-Clínico

UNIVERSIDAD DE CHILE

Santiago, Chile

2
Alejandro Pacheco

Académico

Kinesiología

Universidad Católica del Maule

Talca, Chile

2
Victor Fajardo

Full Professor

Chemistry

Universidad de Magallanes

Punta Arenas, Chile

2
Leticia Barrientos

Academica Titular

Instituto de Ciencias Biomédicas

Universidad Autónoma de Chile

Temuco, Chile

1
Jorge Veloz

Profesor Asistente

Ciencias Biológicas y Químicas

Universidad San Sebastián

Santiago, Chile

1
María Furrianca

PROFESOR ASOCIADO

DEPARTAMENTO DE ENFERMERÍA

Universidad de Magallanes

Punta Arenas, Chile

1
Jacquelinne Acuña

Asistant professor

CIENCIAS QUIMICAS Y RECURSOS NATURALES

Universidad de La Frontera

Temuco, Chile

1
Milko Jorquera

PROFESOR TITULAR

CIENCIAS QUIMICA Y RECURSOS NATURALES

UNIVERSIDAD DE LA FRONTERA

TEMUCO, Chile

1
Jose Caamaño

Académico a contrata

Medicina Interna

Universidad de La Frontera

Temuco, Chile

1
Jesús Herrera

Director

Ciencias Básicas

Universidad Santo Tomás

Temuco, Chile

1
Gabriel Rojas

Academico

Universidad Autónoma de Chile

Talca, Chile

1
Luis Quinones

PROFESOR TITULAR

ONCOLOGIA BASICO-CLINICA

UNIVERSIDAD DE CHILE

Santiago, Chile